These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25888250)

  • 1. Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial.
    Tsai TH; Lu CH; Wallace CG; Chang WN; Chen SF; Huang CR; Tsai NW; Lan MY; Sung PH; Liu CF; Yip HK
    Crit Care; 2015 Feb; 19(1):49. PubMed ID: 25888250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human erythropoietin in the treatment of acute ischemic stroke.
    Ehrenreich H; Weissenborn K; Prange H; Schneider D; Weimar C; Wartenberg K; Schellinger PD; Bohn M; Becker H; Wegrzyn M; Jähnig P; Herrmann M; Knauth M; Bähr M; Heide W; Wagner A; Schwab S; Reichmann H; Schwendemann G; Dengler R; Kastrup A; Bartels C;
    Stroke; 2009 Dec; 40(12):e647-56. PubMed ID: 19834012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke.
    Yip HK; Tsai TH; Lin HS; Chen SF; Sun CK; Leu S; Yuen CM; Tan TY; Lan MY; Liou CW; Lu CH; Chang WN
    Crit Care; 2011; 15(1):R40. PubMed ID: 21269484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of acute versus convalescent stage high-sensitivity C-Reactive protein level in predicting clinical outcome after acute ischemic stroke and impact of erythropoietin.
    Yeh KH; Tsai TH; Chai HT; Leu S; Chung SY; Chua S; Chen YL; Lin HS; Yuen CM; Yip HK
    J Transl Med; 2012 Jan; 10():6. PubMed ID: 22222005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric dimethylarginine in response to recombinant tissue-type plasminogen activator and erythropoietin in acute stroke.
    Worthmann H; Martens-Lobenhoffer J; Joumaah M; Li N; Lichtinghagen R; Hecker H; Kielstein JT; Ehrenreich H; Bode-Böger SM; Weissenborn K
    Stroke; 2013 Aug; 44(8):2128-33. PubMed ID: 23788583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical analysis plan for the Erythropoietin in Traumatic Brain Injury trial: a randomised controlled trial of erythropoietin versus placebo in moderate and severe traumatic brain injury.
    Presneill J; Little L; Nichol A; French C; Cooper DJ; Haddad S; Duranteau J; Huet O; Skrifvars M; Arabi Y; Bellomo R; ;
    Trials; 2014 Dec; 15():501. PubMed ID: 25528574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial.
    Oskouei DS; Rikhtegar R; Hashemilar M; Sadeghi-Bazargani H; Sharifi-Bonab M; Sadeghi-Hokmabadi E; Zarrintan S; Sharifipour E
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e557-63. PubMed ID: 23871729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human choriogonadotropin and epoetin alfa in acute ischemic stroke patients (REGENESIS-LED trial).
    Cramer SC; Hill MD;
    Int J Stroke; 2014 Apr; 9(3):321-7. PubMed ID: 24588854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
    Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
    Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.
    Hacke W; Albers G; Al-Rawi Y; Bogousslavsky J; Davalos A; Eliasziw M; Fischer M; Furlan A; Kaste M; Lees KR; Soehngen M; Warach S;
    Stroke; 2005 Jan; 36(1):66-73. PubMed ID: 15569863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Tirofiban in acute Ischemic Stroke: the SaTIS trial.
    Siebler M; Hennerici MG; Schneider D; von Reutern GM; Seitz RJ; Röther J; Witte OW; Hamann G; Junghans U; Villringer A; Fiebach JB
    Stroke; 2011 Sep; 42(9):2388-92. PubMed ID: 21852609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable outcome of ischemic stroke in patients pretreated with statins.
    Martí-Fàbregas J; Gomis M; Arboix A; Aleu A; Pagonabarraga J; Belvís R; Cocho D; Roquer J; Rodríguez A; García MD; Molina-Porcel L; Díaz-Manera J; Martí-Vilalta JL
    Stroke; 2004 May; 35(5):1117-21. PubMed ID: 15073403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin Treatment in Patients with Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Yao X; Wang D; Li H; Shen H; Shu Z; Chen G
    Curr Drug Deliv; 2017 Sep; 14(6):853-860. PubMed ID: 27549753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrolysin dose-dependently improves neurological outcome in rats after acute stroke: A prospective, randomized, blinded, and placebo-controlled study.
    Zhang L; Chopp M; Lu M; Zhang T; Winter S; Doppler E; Meier D; Chao L; Eapen A; Pabla P; Gang Zhang Z
    Int J Stroke; 2016 Apr; 11(3):347-55. PubMed ID: 26763925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1).
    Lampl Y; Zivin JA; Fisher M; Lew R; Welin L; Dahlof B; Borenstein P; Andersson B; Perez J; Caparo C; Ilic S; Oron U
    Stroke; 2007 Jun; 38(6):1843-9. PubMed ID: 17463313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke.
    Lang W; Stadler CH; Poljakovic Z; Fleet D;
    Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NXY-059 for acute ischemic stroke.
    Lees KR; Zivin JA; Ashwood T; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Hårdemark HG; Wasiewski WW;
    N Engl J Med; 2006 Feb; 354(6):588-600. PubMed ID: 16467546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Outcomes in Patients Aged ≤70 Years With Intravenous Glyburide From the Phase II GAMES-RP Study of Large Hemispheric Infarction: An Exploratory Analysis.
    Sheth KN; Petersen NH; Cheung K; Elm JJ; Hinson HE; Molyneaux BJ; Beslow LA; Sze GK; Simard JM; Kimberly WT
    Stroke; 2018 Jun; 49(6):1457-1463. PubMed ID: 29789393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early high-dose erythropoietin therapy and hypothermia after out-of-hospital cardiac arrest: a matched control study.
    Cariou A; Claessens YE; Pène F; Marx JS; Spaulding C; Hababou C; Casadevall N; Mira JP; Carli P; Hermine O
    Resuscitation; 2008 Mar; 76(3):397-404. PubMed ID: 18037223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.